December 22, 2025

AGA strengthens payor ties to ease admin burden

“We view this as an opportunity to work together to alleviate some of these burdens, and I will say that hearing the perspective from payors has been very eye-opening.”

Conexiant

December 05, 2025

Fancy Gadgets, Higher Bills: HSA Era

Republican proposals to expand health savings accounts amid expiring ACA subsidies outline potential shifts in coverage costs and limitations in how patients may use HSA funds.

KFF Health News

December 02, 2025

‘Liver Cancer Has Disappeared in Children’: But for How Long?

A review of the hepatitis B birth-dose recommendation examines vaccination practices, transmission risks, and potential impacts on newborn protection.

KFF Health News

November 30, 2025

Mount Sinai Helps Set a New Standard for Treating Alcohol-Related Liver Disease

Mount Sinai has become a leading site for the treatment of alcohol-related liver disease in the New York metropolitan region, and one of a handful in the country with a comprehensive center for addressing the sizable population of patients with both liver disease and alcohol addiction.

Mount Sinai New York

November 25, 2025

FDA Approves Reformulated Ranitidine

The reformulated heartburn medication comes with strict storage requirements

Conexiant

April 26, 2024

Lack of Widespread Adoption of Nonstigmatizing Language on Liver Transplant Center Websites

Stigmatizing language on transplant websites may deter patients with alcohol use disorder and alcohol-associated liver disease from seeking necessary medical care.

Conexiant

May 01, 2024

Chronic Liver Disease in Latinx Pediatric Patients: Risk Factor Potentially Identified as Cases Rise

Investigators may have uncovered a new factor contributing to the rising incidence of metabolic dysfunction–associated steatotic liver disease among Latinx pediatric patients.

Conexiant

November 07, 2024

Zinc: Missing Link in HE Management?

Study reveals stark survival contrast: cirrhotic patients with normal zinc levels showed 86% survival rate versus significantly poorer outcomes in zinc-deficient patients (35.56 ± 11.65 mcg/dL, P<.0001), suggesting a potentially modifiable risk factor in hepatic encephalopathy management.

Conexiant

November 12, 2024

Gut Bacteria Linked to Insulin Resistance

Study highlights how 'Proteobacteria and bile acids in the gut negatively impact insulin sensitivity,' offering potential therapeutic targets across the microbiome-gut-adipose-liver axis.

Conexiant